US Stock MarketDetailed Quotes
DRUG Bright Minds Biosciences
- 35.3300
- +2.9500+9.11%
Close Nov 22 16:00 ET
- 33.3400
- -1.9900-5.63%
Post 20:01 ET
245.49MMarket Cap-56079P/E (TTM)
36.7200High31.3500Low241.75KVolume31.4100Open32.3800Pre Close8.43MTurnover9.05%Turnover RatioLossP/E (Static)6.95MShares79.020052wk High56.26P/B94.36MFloat Cap0.930052wk Low--Dividend TTM2.67MShs Float79.0200Historical High--Div YieldTTM16.58%Amplitude0.9300Historical Low34.8810Avg Price1Lot Size
About Bright Minds Biosciences Company
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
Company Profile
SymbolDRUG
Company NameBright Minds Biosciences
Listing DateNov 8, 2021
Founded2019
CEOMr. Ian McDonald
MarketNASDAQ
Employees1
Fiscal Year Ends09-30
Address19 Vestry Street
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10013
Company Executives
- Name
- Position
- Salary
- Ian McDonald
- President, Chief Executive Officer and Director
- 626.18K
- Dr. Jan Pedersen, M.Sc.
- Director and Chief Science Officer
- 799.72K
- Ryan E. Cheung
- Chief Financial Officer
- 120.00K
- Dr. Mark A. Smith
- Chief Medical Officer
- 450.92K
- Nils Christian Bottler
- Independent Director
- 7.69K
- Jeremy Fryzuk
- Independent Director
- 7.69K
- Dr. David M. Weiner, M.D.
- Independent Director
- 22.04K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data